Genotype-phenotype correlation in cystic fibrosis: The role of modifier genes

American Journal of Medical Genetics

Volumn 111, Issue 1, 2002, Pages 88-95

  Salvatore, Francesco ^a,c   Scudiero, Olga ^a   Castaldo, Giuseppe ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c Dipartimento di Biochimica e Biotecnologie Mediche   (Italy)

Author keywords

Cystic fibrosis; Genotype Phenotype correlation; Modifier genes

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA DEFENSIN; MANNAN BINDING LECTIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENVIRONMENTAL FACTOR; FEMALE; GASTROINTESTINAL DISEASE; GENE LOCUS; GENE MUTATION; GENOTYPE; HEREDITY; HUMAN; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; NONSENSE MUTATION; PANCREAS INSUFFICIENCY; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SIBLING; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; COMPARATIVE STUDY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; GENE EXPRESSION REGULATION; GENETIC EPISTASIS; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETICS; INTESTINE OBSTRUCTION; LIVER; LUNG; MECONIUM; METABOLISM; MOUSE; MULTIFACTORIAL INHERITANCE; MUTATION; PANCREAS; PATHOLOGY; REVIEW; STOP CODON;

ANIMAL; CODON, NONSENSE; COMPARATIVE STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INTESTINAL OBSTRUCTION; LIVER; LUNG; MECONIUM; MICE; MICE, INBRED CFTR; MULTIFACTORIAL INHERITANCE; MUTATION; ORGAN SPECIFICITY; PANCREAS; PHENOTYPE; POLYMORPHISM (GENETICS); SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS; POLYMORPHISM, GENETIC;

EID: 0037157787     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.10461     Document Type: Article

References (87)

1. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis
2. Variability of clinical phenotype in twins and siblings with cystic fibrosis: First epidemiological results of the European Cystic Fibrosis Twin and Sibling Study
3. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
4. Molecular basis of phenotype heterogeneity in cystic fibrosis
5. Pancreatic function and gene deletion F508 in cystic fibrosis
6. Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: Detection of 90% of molecular defects and identification of three novel mutations
7. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress
8. Cystic fibrosis in Spain: High frequency of mutation G542X in the Mediterranean coastal area
9. Clinical features of cystic fibrosis patients bearing rare genotypes
10. Severe liver impairment in a cystic fibrosis affected child homozygous for the G542X mutation
11. Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: Implications in screening for the disease and phenotype characterization for patients with homozygote mutation
12. Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype
13. Mutation analysis in 600 French cystic fibrosis patients
14. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
15. Association of alleles of surfactant proteins A1 and A2 genes with severity of lung disease in 135 adults with cystic fibrosis
16. Analysis of risk factors for the development of liver disease associated with cystic fibrosis
17. Familial concordance of pancreatic function in cystic fibrosis
18. Four new mutations of the CFTR gene (541delC, R347H, R352Q, E585X) detected by DGGE analysis in Italian CF patients, associated with different clinical phenotypes
19. A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew
20. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation
21. A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein
22. Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease
23. Correlation between genotype and phenotype in patients with cystic fibrosis
24. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens
25. Genotype-Phenotype correlation in cystic fibrosis patients compound heterozygotes for the A455E mutation
26. Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients
27. Haplotypes in cystic fibrosis patients with or without pancreatic insufficiency from four European populations
28. A comprehensive genetic map of the human genome based on 5,264 microsatellites
29. Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis
30. Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients
31. Association of variant alleles of mannose-binding lectin with severity of liver disease in cystic fibrosis
32. Genotype-Phenotype correlation in cystic fibrosis patients
33. Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency
34. Cystic fibrosis patients with liver disease are not genetically distinct
35. Cystic fibrosis syndrome: A new paradigm for inherited disorders and implications for molecular diagnostics
36. Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: Association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease
37. Complex multigenic inheritance influences the development of severe liver disease in CF
38. Mild clinical phenotype associated with R1158X/S549R(T > G) CFTR genotype
39. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: Cohort study
40. A cystic fibrosis mutation associated with mild lung disease
41. Association of mannose binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis
42. The genotype of a new linked DNA marker, MP6d-9, is related to the clinical course of cystic fibrosis
43. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis
44. Cystic fibrosis patients bearing both the common missense mutation Gly-Asp at codon 551 and the ΔF508 mutation are clinically indistinguishable from ΔF508 homozygotes, except for decreased risk of meconium ileus
45. An alpha(1)-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis
46. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
47. Tumor necrosis factor alpha gene polymorphism in chronic bronchitis
48. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis
49. Trinucleotide repeat polymorphism at the D19S190 locus
50. Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation
51. Lung disease in mice with cystic fibrosis
52. Genotype-Phenotype correlations in cystic fibrosis
53. Identification of the cystic fibrosis gene: Genetic analysis
54. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis
55. Clinical and genetic comparison of patients with cystic fibrosis, with or without meconium ileus
56. The relation between genotype and phenotype in cystic fibrosis analysis of the most common mutation (ΔF508)
57. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease control subjects
58. Genetic determination of pancreatic function in cystic fibrosis
59. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis
60. Secondary genetic factors in cystic fibrosis lung disease
61. Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disese
62. Alpha-1 antitrypsin deficiency alleles and the Taq-I G > A allele in cystic fibrosis lung disease
63. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens
64. Genetic differences between cystic fibrosis with and without meconium ileus
65. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection
66. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Steel and Coal Statement of the European Respiratory Society
67. Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution
68. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
69. Is the hemochromatosis gene a modifier locus for cystic fibrosis?
70. Identification of the cystic fibrosis gene: Chromosome walking and jumping
71. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
72. Psudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells
73. Lung involvement, the delta F508 mutation and DNA haplotype analysis in cystic fibrosis
74. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis
75. Genotype-Phenotype relationship in cystic fibrosis: Results from the study of monozygotic and dizygotic twins with cystic fibrosis
76. Prevalence of liver disease in cystic fibrosis
77. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease
78. Production of β-defensins by human airway epithelia
79. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
80. Liver disease in cystic fibrosis
81. Rapid method for the determination of fat in feces
82. High frequency of polymorphisms in the human β-defensin 1 gene
83. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis
84. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
85. In vivo measurements of ion transport in long-living CF mice
86. A cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13